 |
0 Diseases |  |
6 Trials |
|
6 Trials |  |
205 News |  |
| «12345 |
- ||| Sublocade (buprenorphine once-monthly depot) / Indivior
Enrollment closed, Trial primary completion date: Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects (clinicaltrials.gov) - Sep 29, 2014
P2, N=90, Active, not recruiting, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Sep 2013
- | Sublocade (buprenorphine once-monthly depot) / Indivior
Enrollment open: Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder (clinicaltrials.gov) - Jan 23, 2014
P2, N=30, Recruiting, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Sep 2013 Not yet recruiting --> Recruiting
- | Sublocade (buprenorphine once-monthly depot) / Indivior
New P2 trial: Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder (clinicaltrials.gov) - Jan 21, 2014
P2, N=30, Recruiting, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.
- ||| Sublocade (buprenorphine once-monthly depot) / Indivior
Enrollment change: Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects (clinicaltrials.gov) - Jan 14, 2014
P2, N=90, Recruiting, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.
Not yet recruiting --> Recruiting N=45 --> 90
- ||||| Sublocade (buprenorphine once-monthly depot) / Indivior
New P2 trial: Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects (clinicaltrials.gov) - Nov 28, 2012
P2, N=90, Recruiting, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.